Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis

Autor: Jia, Yijiang, Taledaohan, Ayijiang, Jia, Renbo, Wang, Xin, Jia, Yunshu, Liu, Jiawang, Wang, Yuji

Publikováno v: In Biomedicine & Pharmacotherapy December 2023 168

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors

Autor: Song, Songlin, Gui, Lin, Feng, Qiqi, Taledaohan, Ayijiang, Li, Yuanming, Wang, Wei, Wang, Yanming, Wang, Yuji

Publikováno v: International Journal of Nanomedicine
6659–6671

Songlin Song,1,2 Lin Gui,1,2 Qiqi Feng,1,2 Ayijiang Taledaohan,1,2 Yuanming Li,3 Wei Wang,4 Yanming Wang,5 Yuji Wang1,2 1School of Pharmaceutical Sciences of Capital Medical University, Beijing 100069, People’s Republic of China; 2Beijing Area Majo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::69c6028ef5a831f776eba2e5f60f3af9
https://pubmed.ncbi.nlm.nih.gov/32982225

The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors.

Autor: Liu B; Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing 100069, China.; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China., Lu Y; Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing 100069, China.; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.; Department of Core Facility Center, Capital Medical University, Beijing 100069, China., Taledaohan A; Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing 100069, China.; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China., Qiao S; Civil Aviation Medical Center, Civil Aviation Administration of China, Beijing 100123, China., Li Q; Civil Aviation Medical Center, Civil Aviation Administration of China, Beijing 100123, China., Wang Y; Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, Beijing 100069, China.; Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China, Beijing Laboratory of Biomedical Materials, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.; Department of Core Facility Center, Capital Medical University, Beijing 100069, China.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2023 Dec 22; Vol. 29 (1). Date of Electronic Publication: 2023 Dec 22.